COMPARISON OF A LOW-MOLECULAR-WEIGHT HEPARIN AND THROMBIN ACTIVE-SITE INHIBITOR IN EXPERIMENTAL ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING-TIME

被引:0
|
作者
SCHUMACHER, WA [1 ]
STEINBACHER, TE [1 ]
HERAN, CL [1 ]
机构
[1] BRISTOL MYERS SQUIBB CO,DEPT PHARMACOL,PRINCETON,NJ
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:657 / 657
页数:1
相关论文
共 50 条
  • [1] Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time
    Schumacher, WA
    Heran, CL
    Steinbacher, TE
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1996, 28 (01) : 19 - 25
  • [2] COMPARISON OF THROMBIN ACTIVE-SITE AND EXOSITE INHIBITORS AND HEPARIN IN EXPERIMENTAL-MODELS OF ARTERIAL AND VENOUS THROMBOSIS AND BLEEDING
    SCHUMACHER, WA
    STEINBACHER, TE
    HERAN, CL
    SEILER, SM
    MICHEL, IM
    OGLETREE, ML
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (03): : 1237 - 1242
  • [3] Effects of inogatran, a new low-molecular-weight thrombin inhibitor, in rat models of venous and arterial thrombosis, thrombolysis and bleeding time
    Gustafsson, D
    Elg, M
    Lenfors, S
    Borjesson, I
    TegerNilsson, AC
    BLOOD COAGULATION & FIBRINOLYSIS, 1996, 7 (01) : 69 - 79
  • [4] EFFECT OF A NOVEL THROMBIN ACTIVE-SITE INHIBITOR ON ARTERIAL AND VENOUS THROMBOSIS
    SCHUMACHER, WA
    BALASUBRAMANIAN, N
    STLAURENT, DR
    SEILER, SM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 259 (02) : 165 - 171
  • [5] LOW-MOLECULAR-WEIGHT HEPARIN AND VENOUS THROMBOSIS
    LAST, EC
    ANNALS OF INTERNAL MEDICINE, 1991, 114 (04) : 338 - 338
  • [6] LOW-MOLECULAR-WEIGHT HEPARIN FOR DEEP VENOUS THROMBOSIS
    FAIVRE, R
    NEUHART, E
    BASSAND, JP
    MAURAT, JP
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (17): : 2507 - 2507
  • [7] LOW-MOLECULAR-WEIGHT HEPARIN FOR VENOUS THROMBOSIS IN A NEONATE
    DZUMHUR, SM
    GOSS, DE
    COHEN, AT
    LANCET, 1995, 346 (8988): : 1487 - 1487
  • [8] E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis
    Myers, Daniel D., Jr.
    Ning, Junjie
    Lester, Patrick
    Adili, Reheman
    Hawley, Angela
    Durham, Laura
    Dunivant, Veronica
    Reynolds, Garrett
    Crego, Kiley
    Sood, Suman
    Sigler, Robert
    Fogler, William E.
    Magnani, John L.
    Holinstat, Michael
    Wakefield, Thomas
    JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS, 2022, 10 (01) : 211 - 220
  • [9] Combinations of low doses of unfractionated heparin and of low-molecular-weight heparin prevent experimental venous thrombosis
    Carelli, Guareide
    Maffei, Francisco H. A.
    Mattar, Luci
    Ferrari, Iracerna C.
    Thomazini-Santos, Izolete A.
    de Carvalho, Lidia R.
    PATHOPHYSIOLOGY OF HAEMOSTASIS AND THROMBOSIS, 2005, 34 (06) : 263 - 268
  • [10] INFLUENCE OF HEPARIN AND A LOW-MOLECULAR-WEIGHT HEPARIN FRACTION OF THE LEUKOCYTES IN AN EXPERIMENTAL VENOUS THROMBOSIS MODEL
    DOUTREMEPUICH, C
    TOULEMONDE, F
    DESEZE, O
    PEREIRA, F
    ANNE, MC
    DOUTREMEPUICH, F
    JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 42 (06) : 628 - 631